Gasgon Medical reportedly hopes to raise more than $4.3 million (€4 million) to support its technology for fast, accurate IV delivery. The Cork, Ireland-based medtech startup already has commitments from returning lead investors, according to The Business Post. Founded in 2018, Gasgon develops a medical device that assists healthcare providers in IV (intravenous) administration delivery. The […]
Insulet begins limited rollout of Omnipod 5 with Dexcom G7, grows sales by 38% in Q4
Insulet (Nasdaq: PODD) announced that it began a limited market release of the Omnipod 5 with the Dexcom G7. This marks the latest integration of Dexcom’s next-generation CGM into automated insulin delivery technology. Omnipod 5, Insulet’s newest patch pump offering, previously worked with the G6 in the U.S. It also recently integrated the system with […]
Modular Medical closes $10M public offering
Modular Medical (Nasdaq:MODD) announced that it closed an underwritten public offering worth proceeds of $10 million. The San Diego-based insulin pump maker offered just over 9 million shares of its common stock. It sold each share of common stock to the public at a price of $1.10 per share. Manchester Explorer — managed by Modular […]
FDA: Don’t use smartwatches, smart rings to measure blood glucose
The FDA issued a warning to consumers, patients, caregivers and providers around using certain technology to measure blood glucose. In the warning, the agency outlined the risks related to using smartwatches or smart rings for this purpose. Such devices may claim to measure blood glucose levels without piercing the skin. These devices are different from […]
Tandem stock dips after hours on Q4 misses, 10% growth expected in 2024
Tandem Diabetes Care (Nasdaq:TNDM) shares took a hit after hours on fourth-quarter results that came up short of the consensus forecast. Shares of TNDM fell 8% at $20.74 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day up 0.2%. […]
Narcan nasal spray maker Emergent BioSolutions has a new CEO
Emergent BioSolutions (NSYE:EBS) announced today that it appointed Joseph C. Papa as its new president and CEO. Papa’s appointment to the corner office of the Gaithersburg, Maryland-based company went into effect today. He succeeds Haywood Miller, who stepped down from his role as interim CEO today as well. Emergent BioSolutions is known for its Narcan […]
Enable Injections to expand manufacturing facility to support drug delivery device production
Enable Injections announced today that it plans to expand its manufacturing operations with a new, large-scale facility in Ohio. In addition to the expansion in Springdale, Ohio, the company plans to enhance its corporate headquarters in Evendale, Ohio. Both facilities, nearby one another, sit just outside of Cincinnati. Enable Injections plans for its new 90,000-square-foot […]
Tandem Diabetes Care launches Mobi mini automated insulin patch pump
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it kicked off the U.S. commercial launch of its Mobi insulin patch pump. The San Diego-based company says Mobi, which is fully controllable from a mobile app, is the world’s smallest durable automated insulin delivery (AID) system. It received FDA clearance for people with diabetes ages six and […]
Senseonics earns expanded Medicare coverage for long-term implantable CGM
Senseonics (NYSE:SENS) and Ascensia Diabetes Care today announced expanded Medicare coverage for the Eversense E3 CGM system. Medicare implemented Local Coverage Determinations (LCDs) providing access to implantable CGM for basal-only patients. It significantly expands access to Senseonics’ long-term (six months) implantable glucose monitor. The expansion for implantable CGMs includes all people with diabetes using insulin. […]
Embecta beats The Street in Q1, raises guidance as insulin pump development moves along
Embecta (Nasdaq:EMBC) shares took a hit this morning despite Street-beating first-quarter results and increased 2024 guidance. Shares of EMBC fell 7.8% at $16.37 apiece as the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — opened today relatively even. The Parsippany, New Jersey-based BD Diabetes […]